Tokio Marine Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Tokio Marine Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-43,700	Closed	-$1.13M	–	448
2021 Q1	$1.13M	Hold	43,700	–	–	0.12%	109
2020 Q4	$2.34M	Sell	43,700 -1,700	-4%	-$84.4K	0.25%	54
2020 Q3	$1.87M	Sell	45,400 -600	-1%	-$25.9K	0.23%	53
2020 Q2	$2.23M	Buy	46,000 +500	+1%	+$24K	0.32%	48
2020 Q1	$1.92M	Hold	45,500	–	–	0.33%	51
2019 Q4	$1.95M	Hold	45,500	–	–	0.3%	58
2019 Q3	$1.64M	Buy	45,500 +4,000	+10%	+$121K	0.27%	60
2019 Q2	$1.11M	Hold	41,500	–	–	0.19%	89
2019 Q1	$1.11M	Hold	41,500	–	–	0.21%	90
2018 Q4	$671K	Hold	41,500	–	–	0.14%	107
2018 Q3	$862K	Hold	41,500	–	–	0.15%	98
2018 Q2	$634K	Hold	41,500	–	–	0.12%	128
2018 Q1	$933K	Hold	41,500	–	–	0.16%	128
2017 Q4	$1.25M	Buy	+41,500	New	+$1.33M	0.19%	139

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Tokio Marine Asset Management's ACAD Position: Q2 2021 in Review

Tokio Marine Asset Management sold out of Acadia Pharmaceuticals (ACAD) in Q2 2021, closing a stake of 43,700 shares — an estimated $1.13M sold.

Tokio Marine Asset Management first reported a position in ACAD in Q4 2017 and held it in 14 quarters. The position peaked at $2.34M in Q4 2020. 245 funds tracked by Wall St. Rank hold ACAD as of Q2 2021.

Tokio Marine Asset Management reported no remaining Acadia Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Tokio Marine Asset Management sold 43,700 Acadia Pharmaceuticals shares in Q2 2021, an estimated $1.13M.
Tokio Marine Asset Management first reported a position in Acadia Pharmaceuticals in Q4 2017 and held it in 14 quarters.
Tokio Marine Asset Management's Acadia Pharmaceuticals position peaked at $2.34M in Q4 2020.
245 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2021.

Based on Tokio Marine Asset Management's 13F filing for Q2 2021, filed 12 Aug 2021.